These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1981664)

  • 1. Dopamine agonist activity of 8-OH-DPAT.
    Smith CF; Cutts S
    Arch Int Pharmacodyn Ther; 1990; 306():106-13. PubMed ID: 1981664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
    Millan MJ; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):983-92. PubMed ID: 1672380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(2):135-46. PubMed ID: 1357637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)-induced clonic seizure in mice].
    Fujii E; Nomoto T
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):29-35. PubMed ID: 1831945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
    Dabiré H; Laubie M; Schmitt H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S61-7. PubMed ID: 1702488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
    Foy RA; Myles JL; Wilkerson RD
    J Pharmacol Exp Ther; 1992 May; 261(2):601-6. PubMed ID: 1533667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
    Johnson EA; Tsai CE; Shahan YH; Azzaro AJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):133-41. PubMed ID: 8101215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
    Lecci A; Giuliani S; Santicioli P; Maggi CA
    J Pharmacol Exp Ther; 1992 Jul; 262(1):181-9. PubMed ID: 1352548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y; Yamawaki S
    Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptors in the mouse vas deferens.
    Smith CF; Rowland PB
    Arch Int Pharmacodyn Ther; 1989; 299():144-54. PubMed ID: 2774764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
    Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL
    Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0923), a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptors in the mouse vas deferens but not in the rat vas deferens.
    Martin PL; Kelly M; Cusack NJ
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1342-8. PubMed ID: 7903387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.